GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Kronox Lab Sciences Ltd

Kronox Lab Sciences Board Meeting Scheduled for Q2 FY27 Results Approval

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 30 Oct 2026, 07:41 PM IST  ·  BSE ID: e19a9a9d-0afc-45db-a49d-9de559a31692
View Original BSE Filing (PDF)
💡
In Simple Terms
Kronox Lab Sciences will hold a board meeting on November 5, 2026, to approve its financial results for July-September 2026.
🤖 AI Summary
  • Kronox Lab Sciences Board meeting scheduled for Thursday, November 05, 2026.
  • Agenda includes considering Unaudited Standalone Financial Results for Q2 FY27.
  • Results cover the quarter and half year ended September 30, 2026.
  • Trading window for company insiders closed effective October 01, 2026.
  • Window remains closed until 48 hours post Unaudited Standalone Financial Results declaration.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this intimation of a Board Meeting.
👤
Who Is Affected
All shareholders will be affected by the upcoming financial results, which will provide an update on the company's performance for Q2 FY27 and H1 FY27.
🔍
Management Signal
The scheduling of the board meeting indicates management is proceeding with regular quarterly financial reporting and compliance requirements.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board Meeting on November 05, 2026 — outcomes including Q2 FY27 results.
Declaration of Unaudited Standalone Financial Results for Q2 FY27 and H1 FY27.
Resumption of trading window 48 hours after financial results declaration.
LOW RISK This filing is a routine procedural announcement for an upcoming board meeting, carrying minimal inherent risk.
💡 Investor Takeaway
Kronox Lab Sciences Limited has scheduled a Board Meeting for November 05, 2026, to consider and approve its Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2026. The trading window for insiders remains closed until these results are declared.
📅 Company Track Record
Kronox Lab Sciences had previously intimated a Board Meeting for August 12, 2026, to approve its Q1 FY27 results. The current intimation follows this pattern for Q2 FY27 results.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is Kronox Lab Sciences Ltd's next Board Meeting?
The next Board Meeting of Kronox Lab Sciences Ltd is scheduled for Thursday, November 05, 2026.
What financial results will be considered at the Kronox Lab Sciences Board Meeting?
The Board will consider and approve the Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2026.
When did the trading window close for Kronox Lab Sciences Ltd's insiders?
The trading window for Directors, Officers, and designated employees of Kronox Lab Sciences Ltd closed with effect from October 01, 2026.
How long will the trading window remain closed for Kronox Lab Sciences Ltd?
The trading window will continue to remain closed up to 48 hours after the declaration of the Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2026.

Questions based on this BSE filing only. For information purposes.

📑 More from Kronox Lab Sciences Ltd
Kronox Lab Sciences Board to Convene for Q1 FY27 Unaudited Standalone Results
RESULTS · 05 Aug 2026

All BSE filings we have analysed for Kronox Lab Sciences Ltd.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.